conivaptan has been researched along with solifenacin in 3 studies
| Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (solifenacin) | Trials (solifenacin) | Recent Studies (post-2010) (solifenacin) |
|---|---|---|---|---|---|
| 188 | 17 | 64 | 14 | 0 | 7 |
| Protein | Taxonomy | conivaptan (IC50) | solifenacin (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 6.3096 | |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 4.3 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.024 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | 6.3096 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 4.3 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.918 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 4.3 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 5.3048 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.3096 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for conivaptan and solifenacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for conivaptan and solifenacin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |